Scandinavian Simvastatin Survival Study
The Scandinavian Simvastatin Survival Study (also known as the 4S study), was a multicentre, randomized, double-blind, placebo-controlled clinical trial, which provided the initial data that supported the use of the cholesterol-lowering drug, simvastatin, in people with a moderately raised cholesterol and coronary heart disease (CHD); that is people who had previously had a heart attack or angina. The study was sponsored by the pharmaceutical company Merck and enrolled 4,444 people from 94 centres in Scandinavia.Before the 4S study, it was not proven that lowering cholesterol could prolong life in people who had CHD. The study concluded that secondary prevention with simvastatin in a high risk group with CHD reduced overall mortality by 30%. Published in The Lancet in 1994, it is considered a "landmark paper".
Source: https://en.wikipedia.org/wiki/Scandinavian_Simvastatin_Survival_Study
Created with WikipediaReaderReborn (c) WikipediaReader
Other Videos By WikiReader
2021-09-16 | Irina Liuliakova |
2021-09-16 | Critical Resistance |
2021-09-16 | Automobile Alley (Oklahoma City, Oklahoma) |
2021-09-16 | Wajihullah |
2021-09-16 | Sachin Tanwar |
2021-09-16 | Calopteryx hyalina |
2021-09-16 | West Tisted |
2021-09-16 | Varavis |
2021-09-16 | Yuxin station |
2021-09-16 | Gu Li (Han dynasty) |
2021-09-16 | Scandinavian Simvastatin Survival Study |
2021-09-16 | Bugil High School |
2021-09-16 | Albert Kiplagat Matebor |
2021-09-16 | Cornelius Nary |
2021-09-16 | List of Canadian plants by family P–Q |
2021-09-16 | DeAtley Island |
2021-09-16 | HMS Pelorus (1896) |
2021-09-16 | John Lomakoski |
2021-09-16 | Ficus katendei |
2021-09-16 | Kosakowo, Greater Poland Voivodeship |
2021-09-16 | Bolshoy Utyash |